National Vision Holdings ROE 2015-2019 | EYE

Current and historical return on equity (ROE) values for National Vision Holdings (EYE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. National Vision Holdings ROE for the three months ending June 30, 2019 was 6.30%.
National Vision Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.01B $0.77B 1.84%
2019-03-31 $0.02B $0.76B 2.14%
2018-12-31 $0.02B $0.74B 3.13%
2018-09-30 $0.07B $0.76B 9.53%
2018-06-30 $0.06B $0.73B 10.89%
2018-03-31 $0.05B $0.71B 12.58%
2017-12-31 $0.04B $0.66B 19.34%
2017-06-30 $0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.015B $1.537B
National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores and Vista Optical locations inside Fred Meyer stores and on select military bases. National Vision Holdings, Inc. is headquartered in Duluth, Georgia.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00